Sucrazide MV 0.2mg/500mg/60mg Tablet
Marketer
Anthem Biopharma
Salt Composition
Voglibose (0.2mg) + Metformin (500mg) + Gliclazide (60mg)
Overview Sucrazide MV 0.2mg/500mg/60mg Tablet
Diabetic patients using the triple-combination medication, "Sucrazide MV" (0.2mg/500mg/60mg), benefit from its anti-diabetic properties. This adult-focused treatment for type 2 diabetes mellitus effectively regulates blood glucose. Administer this tablet with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use, regardless of symptom presence or blood glucose control, is crucial. Discontinuation without medical consultation risks elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headaches, and tremors. Maintain regular mealtimes, carry a quick-acting glucose source (e.g., sugary snacks or juice), and avoid alcohol, which increases hypoglycemia risk. Additional potential side effects encompass altered taste, nausea, vomiting, diarrhea, abdominal pain, headaches, edema, blurred vision, and fractures. Weight gain may also occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should discuss use with their physician. Pregnant or lactating women require prior medical consultation. Regular blood glucose monitoring, along with blood tests assessing blood cell counts and liver function, are recommended by your doctor.
Primary Ingredients of Sucrazide MV 0.2mg/500mg/60mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Sucrazide MV 0.2mg/500mg/60mg Tablet
Managing type 2 diabetes
Major Benefits of Sucrazide MV 0.2mg/500mg/60mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Sucrazide MV 0.2mg/500mg/60mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Sucrazide MV 0.2mg/500mg/60mg Tablet:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Sucrazide MV 0.2mg/500mg/60mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sucrazide MV 0.2mg/500mg/60mg tablet whole; avoid crushing, chewing, or fracturing. Administer this medication with a meal.
How Sucrazide MV 0.2mg/500mg/60mg Tablet works:
Diabetic medication, Sucrazide MV, contains 0.2mg/500mg/60mg of three antidiabetic agents per tablet.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Sucrazide MV 0.2mg/500mg/60mg tablets is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Sucrazide MV 0.2mg/500mg/60mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before using this medication.
Breast feedingCAUTION
The use of Sucrazide MV 0.2mg/500mg/60mg tablets while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Sucrazide MV 0.2mg/500mg/60mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates use of Sucrazide MV 0.2mg/500mg/60mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Sucrazide MV 0.2mg/500mg/60mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Low initial doses are typically prescribed for individuals with mild to moderate hepatic dysfunction; however, the medication is contraindicated in those with severe liver disease.
What if you forget to take Sucrazide MV 0.2mg/500mg/60mg Tablet :
NA
Facts to Know About Sucrazide MV 0.2mg/500mg/60mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Diabetes medication |
3,018 People bought this recently